What stem cell therapies for Alzheimer’s are available in Costa Rica?

In Costa Rica, patients living with Alzheimer’s may receive mesenchymal stem cell (MSC) therapy, using cells derived from umbilical cord tissue or their own adipose tissue.

Are there stem cell treatment packages for Alzheimer's patients in Costa Rica?

Yes, the Stem Cells Transplant Institute offers personalized treatment programs for individuals living with Alzheimer’s disease. Packages typically include: Comprehensive medical evaluation Customized MSC treatment protocol Infusion sessions All required laboratory processing Follow-up monitoring after returning home Every program is tailored individually, since Alzheimer’s affects each patient differently and clinical needs vary.

How much does stem cell therapy for Alzheimer’s cost?

Costs vary depending on: The patient’s stage of Alzheimer’s The number of cells and infusions recommended Whether intrathecal (IT) administration or sedation is advised Additional medical services You may request a personalized estimate online, but the final price is provided only after medical review to ensure the proposed plan is appropriate and safe for your condition.

What is the #1 root cause of Alzheimer’s, and can it be reversed?

There is no single known root cause of Alzheimer’s disease. Current scientific understanding indicates it is likely the result from a combination of factors: Abnormal protein accumulation (amyloid and tau) Chronic inflammation Genetic influences Age-related biological changes Oxidative stress Vascular and metabolic factors Because these processes interact overtime, Alzheimer’s cannot be reversed at this stage. However, some treatments—including investigational approaches like stem cell therapy—may help support brain health and stabilize certain functional aspects in patients. Outcomes vary widely from patient to patient.

What does the process look like during and after the transplant?

During treatment: MSCs are administered through a simple intravenous (IV) infusion. Depending on the protocol, an intrathecal (IT) infusion may also be recommended. The procedure is generally well-tolerated and does not usually require general anesthesia. Patients remain under medical supervision throughout the session. After treatment: Most patients resume normal activities within 24 hours. Follow-up evaluations are typically performed at 3 and 6 months to monitor cognitive and functional changes. Improvements, if they occur, tend to appear gradually.

What are the potential risks?

MSC therapy has demonstrated a favorable safety profile in published studies, but- as with any medical procedures- have potential risks. Potential short-term effects may include: Temporary fatigue Mild headache Low-grade fever Dizziness or nausea Discomfort at the infusion site Serious complications are rare but possible. Every patient undergoes a thorough medical evaluation to determine whether MSC therapy is appropriate and to help minimize risk. Emergency support is available on-site.

Stem Cell Therapy for Alzheimer's Disease in Costa Rica

What is Alzheimer’s Disease?

Alzheimer’s disease is a progressive neurodegenerative disorder and the most common cause of dementia in older adults. Its exact cause is not fully understood, but it is characterized by chronic neuroinflammation, gradual neuronal loss, and the accumulation of abnormal proteins in the brain.

According to the World Health Organization (WHO, 2023), over 55 million people worldwide are affected by dementia, with Alzheimer’s accounting for approximately 60–70% of all cases. These changes lead to a decline in memory, thinking, and functional abilities over time.

According to the World Health Organization (WHO, 2023), over 55 million people worldwide are affected by dementia, with Alzheimer’s accounting for nearly 60–70% of all cases.

Why Seek Stem Cell Therapy for Alzheimer’s Disease in Costa Rica?

Stem Cells Transplant Institute in Costa Rica works with families navigating Alzheimer’s disease who are looking for a science-based regenerative option that complements conventional memory care. Our protocols utilize laboratory-processed mesenchymal stem cells and are administered within controlled clinical environments in a certified clinical setting in San José, under direct physician oversight.

Costa Rica is a short, direct flight away from most U.S. and Canadian cities, which facilitates the logistics of traveling internationally with a loved one with Alzheimer’s. Also, for this reason, treatment programs are typically delivered over three to five days, allowing patients and caregivers to complete the clinical protocol within a defined treatment schedule.

Finally, the cost of treatment is substantially lower than comparable private programs in North America.

Before any therapy is scheduled, all Alzheimer’s patients undergo a detailed medical screening and case review conducted by the institute’s physicians. The evaluation process typically involves a review of their diagnosis stage and cognitive status, assessment of current medications and prior treatments, evaluation of medical history and overall health condition, and a discussion with caregivers regarding daily needs support.

Why Stem Cell Therapy for Alzheimer’s?

Emerging scientific research suggests that mesenchymal stem cells may help modulate biological processes associated with Alzheimer’s disease, including chronic inflammation, oxidative stress, and gradual neuronal degeneration.

MSCs are known for their ability to release trophic factors (molecules that support cell survival) that may help reduce oxidative stress and promote a healthier neural environment. They can also regulate immune activity and support the formation of new neural connections (synaptic networks). Early clinical studies have shown that MSCs are capable of migrating toward areas of neural injury without inducing tumor growth or a significant adverse immune response.

While stem cell therapy is not a cure for Alzheimer’s disease, ongoing research indicates that it may offer supportive benefits for selected patients by promoting a more balanced inflammatory response and potentially stabilizing certain functional aspects.

Evidence remains preliminary, and larger controlled clinical trials are required.

Intravenous Infusion of Mesenchymal Stem Cells in Alzheimer’s Disease

Alzheimer’s Research & Therapy • 2021

Phase I clinical trial evaluating safety and tolerability of intravenous mesenchymal stem cell therapy in patients diagnosed with Alzheimer’s disease.

Mesenchymal Stem Cell Therapy and Alzheimer’s Disease: Mechanisms and Evidence

Translational Neurodegeneration • 2020

Scientific review summarizing mechanisms, clinical evidence, and future therapeutic prospects of MSC therapy for Alzheimer’s disease.

Bone Marrow MSC Exosomes Alleviate Cognitive Decline in Alzheimer’s Models

Journal of Neuroinflammation • 2022

Preclinical research showing that mesenchymal stem cell-derived exosomes improved cognitive performance and reduced neuroinflammation in Alzheimer’s models.

MSC-Derived Exosomes Improve Alzheimer’s Pathology

Biomedicines • 2021

Experimental study demonstrating that mesenchymal stem cell exosomes may reduce pathological markers associated with Alzheimer’s disease.

Stem Cell Therapy for Alzheimer’s Disease

What is Alzheimer’s Disease?

Why Seek Stem Cell Therapy for Alzheimer’s Disease in Costa Rica?

Common characteristics

Why Stem Cell Therapy for Alzheimer’s?

Reducing Neuroinflammation

Immune System Regulation

Neuroprotection and Support for Repair Processes

Improving Cerebral Blood Flow

Expected Benefits and Clinical Observations

Timeline of Reported Improvements

Patient Stories & Testimonials

Frequently Asked Questions